Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PICS
PICS logo

PICS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pics NV (PICS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
11.400
1 Day change
-0.09%
52 Week Range
19.950
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

PICS is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 available. The technical setup is mildly constructive, but the recent IPO-related lawsuit and disclosure concerns create a clear overhang. Analyst coverage remains mostly positive on paper, yet the latest price target cuts and commentary show caution about execution and the quality of the reported upside. With no strong Intellectia buy signal and no clear financial snapshot available, I would not call this an immediate buy; I would hold off for now.

Technical Analysis

The stock closed at 11.26, slightly above the previous close of 11.06. MACD histogram is positive and expanding, which supports short-term upside momentum. RSI at 66.642 is near the upper neutral range, suggesting the stock is not deeply overbought but also not cheap. Moving averages are converging, which usually signals a pending directional move rather than a strong established trend. Price is trading above the pivot at 10.549 and below resistance at R1 11.465, so the setup is constructive but not decisive. The near-term pattern estimate suggests modest next-day upside, but weak weekly performance expectations.

Positive Catalysts

  • ["MACD is positive and expanding, showing improving momentum.", "Price is above the pivot level and close to first resistance, indicating the market is still supporting the shares.", "Analyst ratings remain generally positive, with multiple Outperform/Buy views and price targets above the current price.", "Recent commentary suggests AI initiatives may help keep costs controlled and support future growth."]

Neutral/Negative Catalysts

  • ["Rosen Law Firm and other firms filed class action lawsuits tied to alleged IPO disclosure issues, creating a major sentiment overhang.", "The news flow highlights alleged credit evaluation deficiencies and financial reclassifications, which raise transparency concerns.", "RBC and Wolfe both lowered price targets on June 3, showing some moderation in expectations.", "Hedge fund and insider trading trends are neutral, so there is no clear smart-money accumulation signal.", "No recent congress trading data is available, and no influential figure buying/selling was reported."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial snapshot field returned an error. Based on analyst commentary, PicPay reported another consistent quarter in its second quarter as a public company, and guidance was mostly in line with expectations. Analysts also noted that some revenue upside was helped by derivative and hedge accounting impacts rather than core operating strength, which makes the recent operating trend look mixed rather than clearly strong.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is still moderately bullish overall, but recent revisions were less enthusiastic. RBC Capital lowered its price target to $18 from $19 and Wolfe Research cut theirs to $15 from $16, while both kept Outperform ratings. Earlier in April, BTG Pactual initiated at Buy with a $20 target and Bradesco BBI initiated at Outperform with a $21 target. The Wall Street pros view is mixed: bulls point to execution, AI-related efficiency, and an attractive valuation relative to future earnings, while bears are focused on the lawsuit risk, disclosure concerns, and the fact that some recent upside appears tied to accounting effects rather than core growth.

Wall Street analysts forecast PICS stock price to rise
Analyst Rating
0
Wall Street analysts forecast PICS stock price to rise
Buy
Hold
Sell
0
Current: 11.410
sliders
Low
0
Averages
0
High
0
0
Current: 11.410
sliders
Low
0
Averages
0
High
0
RBC Capital
Outperform
maintain
$19 -> $18
AI Analysis
2026-06-03
Reason
RBC Capital
Price Target
$19 -> $18
AI Analysis
2026-06-03
maintain
Outperform
Reason
RBC Capital lowered the firm's price target on PicPay to $18 from $19 and keeps an Outperform rating on the shares. The company delivered another consistent quarter for its second quarter as a public company, with guidance that was largely in line with expectations, the analyst tells investors in a research note. AI initiatives are enabling headcount to remain flat to down, which is freeing up additional investments for future growth via marketing and slightly higher risk opportunities, the firm added.
Wolfe Research
Outperform
to
Outperform
downgrade
$16 -> $15
2026-06-03
Reason
Wolfe Research
Price Target
$16 -> $15
2026-06-03
downgrade
Outperform
to
Outperform
Reason
Wolfe Research lowered the firm's price target on PicPay to $15 from $16 and keeps an Outperform rating on the shares. Despite an across-the-board earnings beat, shares were trading roughly flat after hours on light volume, with the revenue upside largely attributed to derivative and hedge accounting impacts rather than core operating strength, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PICS
Unlock Now

People Also Watch